Cargando…
Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
BACKGROUND: Approximately 2–3% of patients undergoing advanced heart failure therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have chemotherapy-related cardiomyopathy, according to analyses of large databases such as United Network for Organ Sharin...
Autores principales: | Araujo-Gutierrez, Raquel, Ibarra-Cortez, Sergio H., Estep, Jerry D., Bhimaraj, Arvind, Guha, Ashrith, Hussain, Imad, Park, Myung H., Torre-Amione, Guillermo, Trachtenberg, Barry H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048122/ https://www.ncbi.nlm.nih.gov/pubmed/32154004 http://dx.doi.org/10.1186/s40959-018-0029-y |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
por: Chitturi, Kalyan R., et al.
Publicado: (2019) -
Implication of Ventricular Assist Devices in Extracorporeal Membranous Oxygenation Patients Listed for Heart Transplantation
por: Guha, Ashrith, et al.
Publicado: (2019) -
Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis
por: Cordero‐Reyes, Andrea M., et al.
Publicado: (2016) -
Combined Heart-Kidney Transplantation: Indications, Outcomes, and Controversies
por: Ahsan, Syed Adeel, et al.
Publicado: (2022) -
Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients
por: Vejpongsa, Pimprapa, et al.
Publicado: (2022)